​

Organogenesis (ORGO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ORGO Stock Forecast

Organogenesis (ORGO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 89.27% increase from the last price of $3.17.

High: $6 Avg: $6 Low: $6 Last Closed Price: $3.17

ORGO Stock Rating

Organogenesis stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

ORGO Price Target Upside V Benchmarks

TypeNameUpside
StockOrganogenesis89.27%
SectorHealthcare Stocks 23.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.78%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$5.50
Last Closing Price$3.17$3.17$3.17
Upside/Downside--73.50%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-31--4
May, 25-31--4
Apr, 25-31--4
Mar, 25-31--4
Feb, 25-31--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 05, 2025Morgan Stanley$6.00$6.01-0.17%89.27%
Jun 28, 2024Brooks O'NeilLake Street$5.00$2.6489.39%57.73%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 28, 2024Lake StreetBuyinitialise
Dec 27, 2023BTIGBuyBuyhold
May 24, 2023WestPark CapitalHoldinitialise
May 24, 2023BTIGBuyupgrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$0.16$0.73$0.12$0.04$-0.05--
Avg Forecast$0.11$0.42$0.12$0.07$-0.07$0.03$0.11
High Forecast$0.12$0.43$0.12$0.08$-0.06$0.06$0.24
Low Forecast$0.11$0.41$0.12$0.05$-0.08$-0.01$0.04
Surprise %45.45%73.81%--42.86%-28.57%--

Revenue Forecast

$300M $350M $400M $450M $500M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$338.30M$468.06M$450.89M$433.14M$482.04M--
Avg Forecast$336.75M$463.90M$458.80M$441.70M$465.62M$472.93M$510.63M
High Forecast$344.82M$475.02M$469.96M$455.79M$480.47M$488.02M$510.63M
Low Forecast$331.22M$456.28M$449.04M$430.02M$453.30M$460.42M$510.63M
Surprise %0.46%0.90%-1.72%-1.94%3.53%--

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$17.23M$94.20M$15.53M$4.95M$-6.47M--
Avg Forecast$15.25M$55.15M$15.93M$8.66M$-9.73M$1.87M$13.14M
High Forecast$15.73M$56.87M$16.43M$10.39M$-8.34M$8.18M$32.24M
Low Forecast$14.93M$53.97M$15.49M$6.92M$-11.13M$-1.02M$4.84M
Surprise %12.99%70.80%-2.50%-42.87%-33.49%--

ORGO Forecast FAQ

Is Organogenesis stock a buy?

Organogenesis stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Organogenesis is a favorable investment for most analysts.

What is Organogenesis's price target?

Organogenesis's price target, set by 4 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 89.27% change from the previous closing price of $3.17.

How does Organogenesis stock forecast compare to its benchmarks?

Organogenesis's stock forecast shows a 89.27% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the specialty & generic drug manufacturers stocks industry (28.78%).

What is the breakdown of analyst ratings for Organogenesis over the past three months?

  • June 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Organogenesis’s EPS forecast?

Organogenesis's average annual EPS forecast for its fiscal year ending in December 2025 is $0.03, marking a -160.00% decrease from the reported $-0.05 in 2024. Estimates for the following years are.

What is Organogenesis’s revenue forecast?

Organogenesis's average annual revenue forecast for its fiscal year ending in December 2025 is $472.93M, reflecting a -1.89% decrease from the reported $482.04M in 2024. The forecast for.

What is Organogenesis’s net income forecast?

Organogenesis's net income forecast for the fiscal year ending in December 2025 stands at $1.87M, representing a -128.82% decrease from the reported $-6.475M in 2024. Projections indicate .